These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21822457)

  • 21. Survivin, a target to modulate the radiosensitivity of Ewing's sarcoma.
    Greve B; Sheikh-Mounessi F; Kemper B; Ernst I; Götte M; Eich HT
    Strahlenther Onkol; 2012 Nov; 188(11):1038-47. PubMed ID: 23053158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor.
    Knowles HJ; Schaefer KL; Dirksen U; Athanasou NA
    BMC Cancer; 2010 Jul; 10():372. PubMed ID: 20637078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNAi phenotype profiling of kinases identifies potential therapeutic targets in Ewing's sarcoma.
    Arora S; Gonzales IM; Hagelstrom RT; Beaudry C; Choudhary A; Sima C; Tibes R; Mousses S; Azorsa DO
    Mol Cancer; 2010 Aug; 9():218. PubMed ID: 20718987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histone deacetylase inhibitors induce cell death and enhance the apoptosis-inducing activity of TRAIL in Ewing's sarcoma cells.
    Sonnemann J; Dreyer L; Hartwig M; Palani CD; Hong le TT; Klier U; Bröker B; Völker U; Beck JF
    J Cancer Res Clin Oncol; 2007 Nov; 133(11):847-58. PubMed ID: 17486365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-Myc down regulation induced differentiation, early cell cycle exit, and apoptosis in human malignant neuroblastoma cells having wild type or mutant p53.
    Janardhanan R; Banik NL; Ray SK
    Biochem Pharmacol; 2009 Nov; 78(9):1105-14. PubMed ID: 19540207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibroblast growth factor 2 induces differentiation and apoptosis of Askin tumour cells.
    Kim MS; Kim CJ; Jung HS; Seo MR; Juhnn YS; Shin HY; Ahn HS; Thiele CJ; Chi JG
    J Pathol; 2004 Jan; 202(1):103-12. PubMed ID: 14694527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herceptin down-regulates HER-2/neu and vascular endothelial growth factor expression and enhances taxol-induced cytotoxicity of human Ewing's sarcoma cells in vitro and in vivo.
    Guan H; Jia SF; Zhou Z; Stewart J; Kleinerman ES
    Clin Cancer Res; 2005 Mar; 11(5):2008-17. PubMed ID: 15756027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitivity of Ewing's sarcoma to TRAIL-induced apoptosis.
    Kontny HU; Hämmerle K; Klein R; Shayan P; Mackall CL; Niemeyer CM
    Cell Death Differ; 2001 May; 8(5):506-14. PubMed ID: 11423911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon-gamma sensitizes resistant Ewing's sarcoma cells to tumor necrosis factor apoptosis-inducing ligand-induced apoptosis by up-regulation of caspase-8 without altering chemosensitivity.
    Lissat A; Vraetz T; Tsokos M; Klein R; Braun M; Koutelia N; Fisch P; Romero ME; Long L; Noellke P; Mackall CL; Niemeyer CM; Kontny U
    Am J Pathol; 2007 Jun; 170(6):1917-30. PubMed ID: 17525260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelial growth factor expression is up-regulated by EWS-ETS oncoproteins and Sp1 and may represent an independent predictor of survival in Ewing's sarcoma.
    Fuchs B; Inwards CY; Janknecht R
    Clin Cancer Res; 2004 Feb; 10(4):1344-53. PubMed ID: 14977835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma.
    Yang Y; Li H; Zhang F; Shi H; Zhen T; Dai S; Kang L; Liang Y; Wang J; Han A
    J Pathol; 2013 Nov; 231(3):323-34. PubMed ID: 23878072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcoma.
    Guan H; Zhou Z; Gallick GE; Jia SF; Morales J; Sood AK; Corey SJ; Kleinerman ES
    Mol Cancer Ther; 2008 Jul; 7(7):1807-16. PubMed ID: 18644993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The sirtuin 1/2 inhibitor tenovin-1 induces a nonlinear apoptosis-inducing factor-dependent cell death in a p53 null Ewing's sarcoma cell line.
    Marx C; Marx-Blümel L; Lindig N; Thierbach R; Hoelzer D; Becker S; Wittig S; Lehmann R; Slevogt H; Heinzel T; Wang ZQ; Beck JF; Sonnemann J
    Invest New Drugs; 2018 Jun; 36(3):396-406. PubMed ID: 29150734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted therapies in Ewing's sarcoma.
    Scotlandi K
    Adv Exp Med Biol; 2006; 587():13-22. PubMed ID: 17163152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic efficacy of a novel combination therapy controls growth of Bcl-x(L) bountiful neuroblastoma cells by increasing differentiation and apoptosis.
    Mohan N; Banik NL; Ray SK
    Cancer Biol Ther; 2011 Nov; 12(9):846-54. PubMed ID: 21878749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined transcriptional and translational targeting of EWS/FLI-1 in Ewing's sarcoma.
    Mateo-Lozano S; Gokhale PC; Soldatenkov VA; Dritschilo A; Tirado OM; Notario V
    Clin Cancer Res; 2006 Nov; 12(22):6781-90. PubMed ID: 17121899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticancer effects of the PLK4 inhibitors CFI-400945 and centrinone in Ewing's sarcoma cells.
    Kerschner-Morales SL; Kühne M; Becker S; Beck JF; Sonnemann J
    J Cancer Res Clin Oncol; 2020 Nov; 146(11):2871-2883. PubMed ID: 32770382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apoptotic responsiveness of the Ewing's sarcoma family of tumours to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Van Valen F; Fulda S; Truckenbrod B; Eckervogt V; Sonnemann J; Hillmann A; Rödl R; Hoffmann C; Winkelmann W; Schäfer L; Dockhorn-Dworniczak B; Wessel T; Boos J; Debatin KM; Jürgens H
    Int J Cancer; 2000 Oct; 88(2):252-9. PubMed ID: 11004677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-(4-Hydroxyphenyl) retinamide potentiated paclitaxel for cell cycle arrest and apoptosis in glioblastoma C6 and RG2 cells.
    Janardhanan R; Butler JT; Banik NL; Ray SK
    Brain Res; 2009 May; 1268():142-153. PubMed ID: 19285047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current Status and Perspectives of Patient-Derived Models for Ewing's Sarcoma.
    Kondo T
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32899796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.